- Category
- Micro (2020-21)
- Udyam number
- UDYAM-MP-23-0004637

Strengthen Pharma Limited
About Strengthen Pharma Limited
Data last updated:
Strengthen Pharma Limited is a public limited company based in Indore, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U52310MP2020PLC052819. Its GSTIN is 23ABECS4576K1Z0 (Madhya Pradesh).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹20,000. It is led by directors including Neha (Whole-Time Director) and Saroj Rani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at ..F – 75 II Lavkush Awash Vihar F.75 II Lavkush Awash Vihar, Indore, Madhya Pradesh, India – 452001.
As per the financials filed for FY 2025, the company reported a revenue of ₹21.35 Lakh. For the same year it recorded a net profit of ₹31,668 (net margin 1.5%) and EBITDA of ₹1.39 Lakh (EBITDA margin 6.5%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years.
Strengthen Pharma Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0004637).
Company details
Recognitions & Rankings of Strengthen Pharma
Contact details
Strengthen Pharma Limited's registered office is in Indore, Madhya Pradesh.
- Registered Address..F – 75 II Lavkush Awash Vihar F.75 II Lavkush Awash Vihar, Indore, Madhya Pradesh, India – 452001
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Strengthen Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Strengthen Pharma Limited, buy the company report.
Financials of Strengthen Pharma Limited
FY 2025 filings availableStrengthen Pharma Limited reported revenue of ₹21.35 Lakh for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 6% over three years. EBITDA rose 158% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.39 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹31,668 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.5% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Strengthen Pharma Limited, buy the company report.
Board of directors of Strengthen Pharma Limited
Strengthen Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saroj Rani | Director | 19 Feb 2024 | 2 Years 8 Months | Current |
| Neetesh Jain | Director | 14 Sep 2020 | 6 Years 1 Months | Current |
| Neha Also directs: Strengthen Pharma India Private Limited | Whole-Time Director | 14 Sep 2020 | 6 Years 1 Months | Current |
Peer comparison
Strengthen Pharma Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sunshine Infraprojects Private Limited | ₹21.36 Lakh (FY 2025) | -18.0% | New Delhi, Delhi, India | |||
| Udbiz Mart Private Limited | ₹21.36 Lakh (FY 2024) | -4.0% | Fatehabad, Haryana, India | |||
| Aro Tiles India Private Limited | ₹21.36 Lakh (FY 2025) | 39.0% | Gurgaon, Haryana, India | |||
| Sudhish Industries (OPC) Private Limited | ₹21.36 Lakh (FY 2025) | -50.0% | Gurugram, Haryana, India | |||
| Aaraike Healthcare Private Limited | ₹21.35 Lakh (FY 2021) | Bangalore, Karnataka, India | ||||
| Strengthen Pharma Limitedthis company | ₹21.35 Lakh (FY 2025) | ₹31,668 | 1.5% | Indore, Madhya Pradesh, India | ||
| Klader Private Limited | ₹21.35 Lakh (FY 2021) | 50.0% | Thana, Kerala, India | |||
| Astin Analytics Private Limited | ₹21.35 Lakh (FY 2025) | -78.0% | Chandigarh, India | |||
| Vallabhi Agro Services Private Limited | ₹21.35 Lakh (FY 2025) | 361.0% | Lucknow, Uttar Pradesh, India | |||
| Janus Healthcare Private Limited | ₹21.35 Lakh (FY 2018) | -59.0% | Himachal Pradesh, India | |||
| Praesidio Doctorplus Private Limited | ₹21.35 Lakh (FY 2021) | 28.0% | Gurgaon, Haryana, India |
To see the full peer comparison of Strengthen Pharma Limited, buy the company report.
Legal cases
No court or tribunal cases involving Strengthen Pharma Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Strengthen Pharma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Strengthen Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23ABECS4576K1Z0 | Madhya Pradesh | Active | 16 Oct 2020 |
To see the full GST registrations and return filing status of Strengthen Pharma Limited, buy the company report.
Recent activity
Strengthen Pharma Limited has 5 board changes on record since 2020: 3 appointments and 2 cessations. The latest: Saroj Rani was appointed as Director on 19 Feb 2024.
Frequently asked questions
Strengthen Pharma is an active public limited company based in Indore, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 September 2020 (6+ years old) and is registered under CIN U52310MP2020PLC052819.
Strengthen Pharma has 3 current directors:
- Neha - Whole-Time Director
- Saroj Rani - Director
- Neetesh Jain - Director
The latest financial statements of Strengthen Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Strengthen Pharma is 23ABECS4576K1Z0, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Strengthen Pharma is U52310MP2020PLC052819. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Strengthen Pharma was incorporated on 14 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Strengthen Pharma by revenue are Sunshine Infraprojects Private Limited, Udbiz Mart Private Limited, Aro Tiles India Private Limited, Sudhish Industries (OPC) Private Limited, Aaraike Healthcare Private Limited and 5 more, all in the same principal business activity (retail trading).
Saroj Rani was appointed as Director on 19 Feb 2024. Neha ceased to be Director on 20 Jan 2022. Siddharth Jain ceased to be Director on 20 Jan 2022. Strengthen Pharma has 5 board changes on record in total.
Yes, Strengthen Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-23-0004637).
The registered office of Strengthen Pharma is at ..F – 75 II Lavkush Awash Vihar F.75 II Lavkush Awash Vihar, Indore, Madhya Pradesh, India – 452001.
Strengthen Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

